In vitro models for the assessment of inflammatory and immuno-modulatory effects of the volatile organic compound chlorobenzene
Authors:
- 1 June 2008
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 60 (2-3) , 185-193
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Release of MCP-1 and IL-8 from lung epithelial cells exposed to volatile organic compoundsToxicology in Vitro, 2008
- An experimental model for the determination of immunomodulating effects by volatile compoundsToxicology in Vitro, 2005
- Glutathione Depletion in CYP2E1-Expressing Liver Cells Induces Toxicity Due to the Activation of p38 Mitogen-Activated Protein Kinase and Reduction of Nuclear Factor-κB DNA Binding ActivityMolecular Pharmacology, 2004
- Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.Journal of Experimental Medicine, 1992
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Toxicology updateJournal of Applied Toxicology, 1990
- Biological monitoring of exposure to monochlorobenzeneInternational Archives of Occupational and Environmental Health, 1990
- Temporal and dose-response features of monochlorobenzene hepatotoxicity in ratsFundamental and Applied Toxicology, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- MonochlorobenzeneJournal of Applied Toxicology, 1981